RalGDS is required for tumor formation in a model of skin carcinogenesis

Cancer Cell. 2005 Mar;7(3):219-26. doi: 10.1016/j.ccr.2005.01.029.

Abstract

To investigate the role of signaling by the small GTPase Ral, we have generated mice deficient for RalGDS, a guanine nucleotide exchange factor that activates Ral. We show that RalGDS is dispensable for mouse development but plays a substantial role in Ras-induced oncogenesis. Lack of RalGDS results in reduced tumor incidence, size, and progression to malignancy in multistage skin carcinogenesis, and reduced transformation by Ras in tissue culture. RalGDS does not appear to participate in the regulation of cell proliferation, but instead controls survival of transformed cells. Experiments performed in cells isolated from skin tumors suggest that RalGDS mediates cell survival through the activation of the JNK/SAPK pathway. These studies identify RalGDS as a key component in Ras-dependent carcinogenesis in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Transformation, Neoplastic*
  • Disease Models, Animal
  • Disease Progression
  • Humans
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Mice
  • Mice, Knockout
  • Signal Transduction / physiology*
  • Skin Neoplasms* / metabolism
  • Skin Neoplasms* / pathology
  • ral GTP-Binding Proteins / genetics
  • ral GTP-Binding Proteins / metabolism*
  • ral Guanine Nucleotide Exchange Factor / genetics
  • ral Guanine Nucleotide Exchange Factor / metabolism*
  • ras Proteins / metabolism

Substances

  • ral Guanine Nucleotide Exchange Factor
  • JNK Mitogen-Activated Protein Kinases
  • ral GTP-Binding Proteins
  • ras Proteins